John F. Paolini is CHIEF MEDICAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 61,324 shares of KNSA, which is worth approximately $2.47 Million. The most recent transaction as insider was on Sep 02, 2022, when has been sold 507 shares (Class A Common Share) at a price of $11.44 per share, resulting in proceeds of $5,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.3K
0% 3M change
17.84% 12M change
Total Value Held $2.47 Million

John F. Paolini Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 02 2022
SELL
Payment of exercise price or tax liability
$5,800 $11.44 p/Share
507 Reduced 1.38%
36,335 Class A Common Share
Sep 02 2022
BUY
Exercise of conversion of derivative security
-
1,725 Added 4.47%
36,842 Class A Common Share
Mar 21 2022
SELL
Payment of exercise price or tax liability
$18,512 $10.98 p/Share
1,686 Reduced 4.58%
35,117 Class A Common Share
Mar 21 2022
BUY
Exercise of conversion of derivative security
-
5,676 Added 13.36%
36,803 Class A Common Share
Mar 16 2022
SELL
Payment of exercise price or tax liability
$6,058 $10.13 p/Share
598 Reduced 1.88%
31,127 Class A Common Share
Mar 16 2022
BUY
Exercise of conversion of derivative security
-
1,725 Added 5.16%
31,725 Class A Common Share
JFP

John F. Paolini

CHIEF MEDICAL OFFICER
Hamilton, D0

Track Institutional and Insider Activities on KNSA

Follow Kiniksa Pharmaceuticals, Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA